Cargando…

Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults

BACKGROUND & AIMS: Immunosuppression-related symptom experience has not been covered thoroughly in long-term liver transplant recipients. The aim of this study was to assess the symptom experience of immunosuppressive therapy three years after liver transplantation and to correlate it with adher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chaoying, Wang, Genshu, Yi, Huimin, Tan, Jianling, Xu, Chi, Fang, Xiaocui, Yang, Yang, Li, Hua, Chen, Qier, Chen, Guihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832465/ https://www.ncbi.nlm.nih.gov/pubmed/24260427 http://dx.doi.org/10.1371/journal.pone.0080584

Ejemplares similares

Correction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults
por: Wang, Chaoying, et al.
Publicado: (2013)

Retraction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults
Publicado: (2019)

Inhibition of Autophagy Prolongs Recipient Survival Through Promoting CD8(+) T Cell Apoptosis in a Rat Liver Transplantation Model
por: Chen, Xiaolong, et al.
Publicado: (2019)

Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
por: Liu, Yuan-Yuan, et al.
Publicado: (2015)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
Publicado: (2019)

The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
por: Yang, Fan, et al.
Publicado: (2018)

Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449a–MET pathway
por: Wang, Guoying, et al.
Publicado: (2019)

Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients Treated with Liver Transplantation
por: Li, Hui, et al.
Publicado: (2020)

Liver transplantation: immunosuppression and oncology
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2014)

Update on Immunosuppression in Liver Transplantation
por: Tasdogan, Burcak E, et al.
Publicado: (2019)

A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trial
por: Zhang, Yingcai, et al.
Publicado: (2021)

Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
por: Xing, Tonghai, et al.
Publicado: (2013)

Sedative and Immunosuppressive Effects of Dexmedetomidine in Transplantation
por: Lee, Chen-Fang, et al.
Publicado: (2021)

Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials
por: Gu, Jinyang, et al.
Publicado: (2014)

Drug repurposing: Ibrutinib exhibits immunosuppressive potential in organ transplantation
por: Zhang, Qing, et al.
Publicado: (2018)

Immunosuppression in kidney transplantation
por: MUNTEAN, ADRIANA, et al.
Publicado: (2013)

Severe Anti-N-Methyl-D-Aspartate Receptor Encephalitis Under Immunosuppression After Liver Transplantation
por: Konen, Franz Felix, et al.
Publicado: (2019)

A Comprehensive Review of Immunosuppression Used for Liver Transplantation
por: Mukherjee, Sandeep, et al.
Publicado: (2009)

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
por: Lee, Jee Hyun, et al.
Publicado: (2009)

Towards Steroid-Free Immunosuppression after Liver Transplantation
por: Zaydfudim, Victor M., et al.
Publicado: (2016)

Liver transplant immunosuppression during the COVID-19 pandemic()
por: Forns, Xavier, et al.
Publicado: (2020)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
Publicado: (2019)

Symptoms experienced by cancer patients and barriers to symptom management
por: Nayak, Malathi G, et al.
Publicado: (2015)

Two Nomograms to Select Hepatocellular Carcinoma Patients with Macroscopic Vascular Invasion for Hepatic Resection
por: Jiang, Yiquan, et al.
Publicado: (2018)

Individualizing immunosuppression in lung transplantation
por: McDermott, Jennifer K., et al.
Publicado: (2018)

Immunosuppressive strategies in lung transplantation
por: Chung, Paul A., et al.
Publicado: (2020)

Innovations in Immunosuppression for Intestinal Transplantation
por: Dogra, Harween, et al.
Publicado: (2022)

Association of time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected bacteria of patients after solid organ transplantation
por: Schmalz, Gerhard, et al.
Publicado: (2018)

Psychological distress experienced by parents caring for an immunosuppressed child during the COVID-19 pandemic
por: Driessens, Corine, et al.
Publicado: (2023)

Graft versus host disease following liver transplantation: A case report
por: ZHANG, CHANGSONG, et al.
Publicado: (2014)

Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigs
por: Shaheen, Mohammed F., et al.
Publicado: (2019)

The Double-Edged Sword of Immunosuppressive Therapy in Kidney Transplantation: A Rare Case Report of Pulmonary Mucormycosis Post-Transplant and Literature Review
por: Zhang, Hengcheng, et al.
Publicado: (2020)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation
por: Lim, Eu Jin, et al.
Publicado: (2015)

Adherence to immunosuppressive therapy following liver transplantation: an integrative review
por: Oliveira, Ramon Antônio, et al.
Publicado: (2016)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
por: Gül-Klein, Safak, et al.
Publicado: (2022)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
por: Zilberg, Catherine, et al.
Publicado: (2022)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

Social support and cognitive function in Chinese older adults who experienced depressive symptoms: is there an age difference?
por: Jing, Yurong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ald0p8e97nmcl6jhj9ncgkum3